Post-IPO Equity Pharmaceutical Companies

Checkpoint Therapeutics is an immuno-oncology biopharmaceutical company specializing in cancer therapy development.

Polarean is manufacturer and service provider for noble gas polarizer devices and ancillary instruments.

Celadon's objective is to improve the quality of life for the most vulnerable people by producing cannabis-based medications.

TFF Pharmaceuticals is a clinical-stage biopharmaceutical company that develops drug products.

Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for treatment.

Acticor Biotech is a biopharmaceutical company developing an innovative drug for the treatment in the acute phase of ischemic stroke.

ASLAN Pharmaceuticals is an oncology-focused biotechnology company developing a portfolio of immuno-oncology agents and targeted therapies.

Newbury Pharmaceuticals is building a pipeline of proprietary and licensed products to become a leading generic pharma company.

Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing medical dermatology for unmet needs.

Autolus is a biopharmaceutical company focused on T-cell programming and manufacturing technology.

Panbela Therapeutics develops small molecule pharmaceuticals for the oncology and acute care markets.

Skye Bioscience is a pharmaceutical company developing new therapeutic outcomes for diseases.

Indiva provide access to medical cannabis.

Rapid Dose Therapeutics is a Pharma-Tech Company that brings drug delivery solutions to a new level.

Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.

Longboard Pharmaceuticals delivers medicines with optimized pharmacology and pharmacokinetics to patients with rare neurological diseases.

Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.

PaxMedica is a biopharmaceutical company focused on developing innovative treatments for unmet needs in neurodevelopmental disorders.

Arcellx develops engineered cell-based immunotherapies for the treatment of cancer and other serious diseases.

Avenue Therapeutics is a specialty pharmaceutical company that acquires/in-licenses, develops and commercializes products.

Cerevel Therapeutics is a biopharmaceutical company that develops drugs to treat neurological and neuropsychiatric disorders.

Aurora Cannabis is a medical marijuana producer that provides its patients quality products, customer service, and affordable pricing.

HilleVax is a biopharmaceutical company that focuses on the development and commercialization of novel vaccines.

Baudax Bio is a specialty pharmaceutical company focused on developing and commercializing innovative products for acute care settings.

Inozyme is a biopharmaceutical company developing therapeutics for rare diseases, with a focus on bone health.